Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia

BACKGROUND AIMS: Several studies have demonstrated that the immunogenicity of chronic lymphocytic leukemia (CLL) cells can be increased by manipulation of the CD40/CD40-ligand (CD40L) pathway. Although immunologic, and perhaps clinical, benefits have been obtained with an autologous CLL tumor vaccin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Okur, Fatma Visal, Yvon, Eric, Biagi, Ettore, Dotti, Gianpietro, Carrum, George, Heslop, Helen, Mims, Martha P., Fratantoni, Joseph C., Peshwa, Madhusudan V., Li, Linhong, Brenner, Malcolm K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687103/
https://ncbi.nlm.nih.gov/pubmed/21745159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2011.592523
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares